Glutamine deprivation stimulates mTOR-JNK-dependent chemokine secretion.

PubWeight™: 0.86‹?›

🔗 View Article (PMC 4200525)

Published in Nat Commun on September 25, 2014

Authors

Naval P Shanware1, Kevin Bray1, Christina H Eng1, Fang Wang1, Maximillian Follettie1, Jeremy Myers1, Valeria R Fantin2, Robert T Abraham2

Author Affiliations

1: Oncology Research Unit, Pfizer Worldwide Research and Development, 401 N. Middletown Road, Pearl River, New York 10965, USA.
2: Oncology Research Unit, Pfizer Worldwide Research and Development, 10777 Science Center Drive, La Jolla, California 92121, USA.

Articles cited by this

Hallmarks of cancer: the next generation. Cell (2011) 140.01

Signal integration in the endoplasmic reticulum unfolded protein response. Nat Rev Mol Cell Biol (2007) 33.06

Guidelines for the use and interpretation of assays for monitoring autophagy in higher eukaryotes. Autophagy (2007) 20.92

The biology of cancer: metabolic reprogramming fuels cell growth and proliferation. Cell Metab (2008) 18.87

p62/SQSTM1 forms protein aggregates degraded by autophagy and has a protective effect on huntingtin-induced cell death. J Cell Biol (2005) 18.23

Ragulator-Rag complex targets mTORC1 to the lysosomal surface and is necessary for its activation by amino acids. Cell (2010) 12.24

Cancer cell metabolism: Warburg and beyond. Cell (2008) 11.80

Myc regulates a transcriptional program that stimulates mitochondrial glutaminolysis and leads to glutamine addiction. Proc Natl Acad Sci U S A (2008) 11.71

Autophagy suppresses tumorigenesis through elimination of p62. Cell (2009) 9.95

Autophagy and metabolism. Science (2010) 8.10

Mammalian autophagy: core molecular machinery and signaling regulation. Curr Opin Cell Biol (2009) 7.96

Bidirectional transport of amino acids regulates mTOR and autophagy. Cell (2009) 7.88

Brick by brick: metabolism and tumor cell growth. Curr Opin Genet Dev (2008) 7.87

Coping with stress: eIF2 kinases and translational control. Biochem Soc Trans (2006) 7.69

Regulation of the mTOR complex 1 pathway by nutrients, growth factors, and stress. Mol Cell (2010) 7.59

The senescence-associated secretory phenotype: the dark side of tumor suppression. Annu Rev Pathol (2010) 7.58

mTORC1 senses lysosomal amino acids through an inside-out mechanism that requires the vacuolar H(+)-ATPase. Science (2011) 7.55

Autophagy suppresses tumor progression by limiting chromosomal instability. Genes Dev (2007) 7.41

The interleukin-8 pathway in cancer. Clin Cancer Res (2008) 7.12

Aerobic glycolysis: meeting the metabolic requirements of cell proliferation. Annu Rev Cell Dev Biol (2011) 7.07

Reductive carboxylation supports growth in tumour cells with defective mitochondria. Nature (2011) 6.57

Glutamine supports pancreatic cancer growth through a KRAS-regulated metabolic pathway. Nature (2013) 6.53

LC3 conjugation system in mammalian autophagy. Int J Biochem Cell Biol (2004) 6.34

Glutamine addiction: a new therapeutic target in cancer. Trends Biochem Sci (2010) 6.30

Termination of autophagy and reformation of lysosomes regulated by mTOR. Nature (2010) 6.26

Q's next: the diverse functions of glutamine in metabolism, cell biology and cancer. Oncogene (2009) 5.81

Multiple control of interleukin-8 gene expression. J Leukoc Biol (2002) 5.35

Characterization of autophagosome formation site by a hierarchical analysis of mammalian Atg proteins. Autophagy (2010) 3.99

The hexosamine biosynthetic pathway couples growth factor-induced glutamine uptake to glucose metabolism. Genes Dev (2010) 3.40

Ammonia derived from glutaminolysis is a diffusible regulator of autophagy. Sci Signal (2010) 3.38

Cancer cell metabolism: one hallmark, many faces. Cancer Discov (2012) 3.03

Ammonia-induced autophagy is independent of ULK1/ULK2 kinases. Proc Natl Acad Sci U S A (2011) 2.91

Glutaminolysis activates Rag-mTORC1 signaling. Mol Cell (2012) 2.82

Spatial coupling of mTOR and autophagy augments secretory phenotypes. Science (2011) 2.58

Therapeutic targets in cancer cell metabolism and autophagy. Nat Biotechnol (2012) 2.27

mTOR, a novel target in breast cancer: the effect of CCI-779, an mTOR inhibitor, in preclinical models of breast cancer. Endocr Relat Cancer (2001) 2.26

Antitumor activity of the glutaminase inhibitor CB-839 in triple-negative breast cancer. Mol Cancer Ther (2014) 2.03

Mammalian target of rapamycin: discovery of rapamycin reveals a signaling pathway important for normal and cancer cell growth. Semin Oncol (2009) 1.98

Beyond rapalog therapy: preclinical pharmacology and antitumor activity of WYE-125132, an ATP-competitive and specific inhibitor of mTORC1 and mTORC2. Cancer Res (2010) 1.86

ATF4 regulates MYC-mediated neuroblastoma cell death upon glutamine deprivation. Cancer Cell (2012) 1.71

Function, structure and regulation of the vacuolar (H+)-ATPases. Arch Biochem Biophys (2008) 1.68

Glutamine: pleiotropic roles in tumor growth and stress resistance. J Mol Med (Berl) (2011) 1.67

Therapeutic targeting of cancer cell metabolism. J Mol Med (Berl) (2011) 1.62

mTORC1 serves ER stress-triggered apoptosis via selective activation of the IRE1-JNK pathway. Cell Death Differ (2011) 1.52

Therapeutic targeting of Myc-reprogrammed cancer cell metabolism. Cold Spring Harb Symp Quant Biol (2011) 1.40

Autophagy in protein and organelle turnover. Cold Spring Harb Symp Quant Biol (2011) 1.38

Delineation of a cellular hierarchy in lung cancer reveals an oncofetal antigen expressed on tumor-initiating cells. Cancer Res (2011) 1.07

Role of V-ATPases in solid tumors: importance of the subunit C (Review). Int J Oncol (2009) 0.88

Interleukin-8 derived from local tissue-resident stromal cells promotes tumor cell invasion. Mol Carcinog (2011) 0.85